Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1995-01-09
1997-05-20
Travers, Russell
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
A61K 3135
Patent
active
056312881
ABSTRACT:
A novel therapeutical utilization of L-carnitine, acyl L-carnitines and the pharmacologically acceptable salts thereof is disclosed, for treating immune and metabolic alterations in patients suffering from AIDS and AIDS-related syndromes and in asymptomatic HIV-seropositive patients.
The L-carnitine amount to be administered according to this novel use is about 6-8 grams daily, via the oral route or an equivalent amount of an acyl L-carnitine or a pharmacologically acceptable salt thereof, i.e. three-four times as much the dose usually administered for the already known therapeutic uses of L-carnitine.
REFERENCES:
patent: 4474812 (1984-10-01), Cavazza
patent: 4968719 (1990-11-01), Brevetti
De Simone et al, AIDS, vol. 6, pp. 203-205 (1992).
Douvos et al 1991, PNAS vol. 88 pp 6328-6332.
Bogden et al 1990, Ann NY Acad Sci #587 pp. 189-195.
Scandurra et al. 1990 113CA109301b.
Marata et al. 1985 102CA218208v.
Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
Travers Russell
LandOfFree
Therapeutic method of treating patients suffering from AIDS and does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic method of treating patients suffering from AIDS and , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic method of treating patients suffering from AIDS and will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1724414